NasdaqGS - Delayed Quote USD
Centessa Pharmaceuticals plc (CNTA)
12.67
+0.52
+(4.28%)
At close: April 22 at 4:00:01 PM EDT
12.67
0.00
(0.00%)
After hours: April 22 at 4:32:39 PM EDT
Insider Purchases Last 6 Months
| Shares | Transactions | |
|---|---|---|
| Purchases | 247,768 | 15 |
| Sales | 660,033 | 24 |
| Net Shares Purchased (Sold) | -412,265 | 39 |
| Total Insider Shares Held | 516.75k | -- |
| % Net Shares Purchased (Sold) | -44.40% | -- |
Net Institutional Purchases Prior Quarter to Latest Quarter
| Shares | |
|---|---|
| Net Shares Purchased (Sold) | -- |
| % Change in Institutional Shares Held | -- |
Insider Transactions Reported - Last Two Years
| Insider | Transaction | Type | Value | Date |
|---|---|---|---|---|
| WEINHOFF GREGORY M Officer | Conversion of Exercise of derivative security at price 3.85 per share. | Direct | 38,500 | Mar 25, 2025 |
| WEINHOFF GREGORY M Officer | Sale at price 16.34 per share. | Direct | 163,386 | Mar 25, 2025 |
| SAHA SAURABH Chief Executive Officer | Sale at price 16.69 per share. | Direct | 918,060 | Mar 20, 2025 |
| HUSSAIN IQBAL J General Counsel | Conversion of Exercise of derivative security at price 5.84 per share. | Direct | 35,040 | Mar 17, 2025 |
| CHAO DAVID M Officer | Conversion of Exercise of derivative security at price 3.85 per share. | Direct | 13,475 | Mar 17, 2025 |
| HUSSAIN IQBAL J General Counsel | Sale at price 16.45 per share. | Direct | 98,697 | Mar 17, 2025 |
| CHAO DAVID M Officer | Sale at price 17.08 - 17.50 per share. | Direct | 120,206 | Mar 17, 2025 |
| WEINHOFF GREGORY M Officer | Sale at price 15.25 per share. | Direct | 175,270 | Feb 25, 2025 |
| SAHA SAURABH Chief Executive Officer | Sale at price 15.92 - 16.54 per share. | Direct | 876,088 | Feb 20, 2025 |
| HUSSAIN IQBAL J General Counsel | Conversion of Exercise of derivative security at price 5.84 per share. | Direct | 35,040 | Feb 18, 2025 |
| HUSSAIN IQBAL J General Counsel | Sale at price 15.91 - 17.05 per share. | Direct | 97,065 | Feb 18, 2025 |
| ANDERSON KAREN M Officer | Conversion of Exercise of derivative security at price 4.01 per share. | Direct | 124,130 | Feb 10, 2025 |
| ANDERSON KAREN M Officer | Sale at price 18.99 - 19.03 per share. | Direct | 588,944 | Feb 10, 2025 |
| ANDERSON KAREN M Officer | Sale at price 16.86 per share. | Direct | 109,124 | Feb 3, 2025 |
| BUSH TIA L Chief Technology Officer | Sale at price 16.86 per share. | Direct | 185,406 | Feb 3, 2025 |
| WEINHOFF GREGORY M Officer | Sale at price 16.47 per share. | Direct | 193,429 | Jan 27, 2025 |
| SAHA SAURABH Chief Executive Officer | Sale at price 15.76 - 16.19 per share. | Direct | 867,430 | Jan 21, 2025 |
| HUSSAIN IQBAL J General Counsel | Conversion of Exercise of derivative security at price 5.84 per share. | Direct | 35,040 | Jan 15, 2025 |
| HUSSAIN IQBAL J General Counsel | Sale at price 15.29 per share. | Direct | 91,740 | Jan 15, 2025 |
| WEINHOFF GREGORY M Officer | Conversion of Exercise of derivative security at price 3.85 per share. | Direct | 38,500 | Dec 26, 2024 |
| WEINHOFF GREGORY M Officer | Sale at price 17.04 per share. | Direct | 170,399 | Dec 26, 2024 |
| SAHA SAURABH Chief Executive Officer | Sale at price 17.44 per share. | Direct | 959,057 | Dec 20, 2024 |
| ANDERSON KAREN M Officer | Conversion of Exercise of derivative security at price 3.85 per share. | Direct | 63,525 | Dec 17, 2024 |
| BUSH TIA L Chief Technology Officer | Conversion of Exercise of derivative security at price 3.85 per share. | Direct | 68,580 | Dec 17, 2024 |
| ANDERSON KAREN M Officer | Sale at price 17.01 - 17.32 per share. | Direct | 284,010 | Dec 17, 2024 |
| BUSH TIA L Chief Technology Officer | Sale at price 16.36 - 18.00 per share. | Direct | 477,890 | Dec 17, 2024 |
| HUSSAIN IQBAL J General Counsel | Conversion of Exercise of derivative security at price 5.84 per share. | Direct | 35,040 | Dec 16, 2024 |
| HUSSAIN IQBAL J General Counsel | Sale at price 16.39 per share. | Direct | 1,273,756 | Dec 16, 2024 |
| SAHA SAURABH Chief Executive Officer | Conversion of Exercise of derivative security at price 5.84 per share. | Direct | 510,977 | Dec 6, 2024 |
| SAHA SAURABH Chief Executive Officer | Sale at price 18.46 per share. | Direct | 1,615,255 | Dec 6, 2024 |
| WEINHOFF GREGORY M Officer | Conversion of Exercise of derivative security at price 3.85 per share. | Direct | 38,500 | Nov 25, 2024 |
| SAHA SAURABH Chief Executive Officer | Conversion of Exercise of derivative security at price 5.84 per share. | Direct | 1,746 | Nov 25, 2024 |
| WEINHOFF GREGORY M Officer | Sale at price 17.66 per share. | Direct | 176,601 | Nov 25, 2024 |
| SAHA SAURABH Chief Executive Officer | Sale at price 18.23 per share. | Direct | 5,451 | Nov 25, 2024 |
| SAHA SAURABH Chief Executive Officer | Conversion of Exercise of derivative security at price 5.84 per share. | Direct | 30,263 | Nov 22, 2024 |
| SAHA SAURABH Chief Executive Officer | Sale at price 16.89 - 18.24 per share. | Direct | 1,023,226 | Nov 22, 2024 |
| SAHA SAURABH Chief Executive Officer | Conversion of Exercise of derivative security at price 5.84 per share. | Direct | 187,014 | Nov 13, 2024 |
| SAHA SAURABH Chief Executive Officer | Sale at price 18.28 per share. | Direct | 585,419 | Nov 13, 2024 |
| WEINHOFF GREGORY M Officer | Sale at price 15.38 per share. | Direct | 180,628 | Oct 25, 2024 |
| SAHA SAURABH Chief Executive Officer | Sale at price 15.32 - 15.80 per share. | Direct | 863,727 | Oct 23, 2024 |
| WEINHOFF GREGORY M Officer | Sale at price 15.69 per share. | Direct | 260,724 | Sep 25, 2024 |
| SAHA SAURABH Chief Executive Officer | Sale at price 16.53 per share. | Direct | 908,985 | Sep 20, 2024 |
| WEINHOFF GREGORY M Officer | Conversion of Exercise of derivative security at price 5.84 per share. | Direct | 175,200 | Sep 10, 2024 |
| SAHA SAURABH Chief Executive Officer | Conversion of Exercise of derivative security at price 5.84 per share. | Direct | 1,022,000 | Sep 10, 2024 |
| WEINHOFF GREGORY M Officer | Sale at price 17.00 per share. | Direct | 510,000 | Sep 10, 2024 |
| SAHA SAURABH Chief Executive Officer | Sale at price 16.52 per share. | Direct | 2,891,822 | Sep 10, 2024 |
| WEINHOFF GREGORY M Officer | Conversion of Exercise of derivative security at price 5.84 per share. | Direct | 146,000 | Sep 9, 2024 |
| WEINHOFF GREGORY M Officer | Sale at price 15.00 per share. | Direct | 375,000 | Sep 9, 2024 |
| WEINHOFF GREGORY M Officer | Sale at price 12.17 - 12.29 per share. | Direct | 367,222 | Aug 23, 2024 |
| SAHA SAURABH Chief Executive Officer | Sale at price 12.30 per share. | Direct | 573,905 | Aug 23, 2024 |
Related Tickers
SYRE Spyre Therapeutics, Inc.
13.96
+2.87%
BPMC Blueprint Medicines Corporation
83.41
-0.91%
MRUS Merus N.V.
43.21
-0.05%
AGIO Agios Pharmaceuticals, Inc.
28.00
+2.41%
XENE Xenon Pharmaceuticals Inc.
36.73
+5.85%
CRNX Crinetics Pharmaceuticals, Inc.
31.27
+3.71%
CYTK Cytokinetics, Incorporated
37.81
-0.32%
ACLX Arcellx, Inc.
63.12
+3.59%
CGON CG Oncology, Inc.
20.48
+0.34%
VIGL Vigil Neuroscience, Inc.
1.8000
+7.14%